Industry Research Reports

Home > Reports > Pharma & Healthcare > Attention Deficit and Hyperactivity Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Attention Deficit and Hyperactivity Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-08

Pages: 109 Pages

Report ld: 3009505

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Attention Deficit and Hyperactivity Disorder Market Size(US$)

CAGR 2024-2030

Market Size,2030

USD 30,770

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 20,500 million

Market Forecast in 2030(Value)

US$ 30,770 million

CAGR

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.

The global market for Attention Deficit and Hyperactivity Disorder was estimated to be worth US$ 19160 million in 2023 and is forecast to a readjusted size of US$ 30770 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030

The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.

MARKET SEGMENTATION

By Company

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Stimulant
Non-stimulant

Segment by Application

Hospital
Retail Pharmacy
Others

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Attention Deficit and Hyperactivity Disorder, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Attention Deficit and Hyperactivity Disorder by region & country, by Type, and by Application.

The Attention Deficit and Hyperactivity Disorder market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit and Hyperactivity Disorder.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Attention Deficit and Hyperactivity Disorder manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Attention Deficit and Hyperactivity Disorder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Attention Deficit and Hyperactivity Disorder in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Attention Deficit and Hyperactivity Disorder Product Introduction

1.2 Global Attention Deficit and Hyperactivity Disorder Market Size Forecast

1.3 Attention Deficit and Hyperactivity Disorder Market Trends & Drivers

1.3.1 Attention Deficit and Hyperactivity Disorder Industry Trends

1.3.2 Attention Deficit and Hyperactivity Disorder Market Drivers & Opportunity

1.3.3 Attention Deficit and Hyperactivity Disorder Market Challenges

1.3.4 Attention Deficit and Hyperactivity Disorder Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Attention Deficit and Hyperactivity Disorder Players Revenue Ranking (2023)

2.2 Global Attention Deficit and Hyperactivity Disorder Revenue by Company (2019-2024)

2.3 Key Companies Attention Deficit and Hyperactivity Disorder Manufacturing Base Distribution and Headquarters

2.4 Key Companies Attention Deficit and Hyperactivity Disorder Product Offered

2.5 Key Companies Time to Begin Mass Production of Attention Deficit and Hyperactivity Disorder

2.6 Attention Deficit and Hyperactivity Disorder Market Competitive Analysis

2.6.1 Attention Deficit and Hyperactivity Disorder Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Attention Deficit and Hyperactivity Disorder Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Stimulant

3.1.2 Non-stimulant

3.2 Global Attention Deficit and Hyperactivity Disorder Sales Value by Type

3.2.1 Global Attention Deficit and Hyperactivity Disorder Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Attention Deficit and Hyperactivity Disorder Sales Value, by Type (2019-2030)

3.2.3 Global Attention Deficit and Hyperactivity Disorder Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Retail Pharmacy

4.1.3 Others

4.2 Global Attention Deficit and Hyperactivity Disorder Sales Value by Application

4.2.1 Global Attention Deficit and Hyperactivity Disorder Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Attention Deficit and Hyperactivity Disorder Sales Value, by Application (2019-2030)

4.2.3 Global Attention Deficit and Hyperactivity Disorder Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Attention Deficit and Hyperactivity Disorder Sales Value by Region

5.1.1 Global Attention Deficit and Hyperactivity Disorder Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Attention Deficit and Hyperactivity Disorder Sales Value by Region (2019-2024)

5.1.3 Global Attention Deficit and Hyperactivity Disorder Sales Value by Region (2025-2030)

5.1.4 Global Attention Deficit and Hyperactivity Disorder Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

5.2.2 North America Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

5.3.2 Europe Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

5.4.2 Asia Pacific Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

5.5.2 South America Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

5.6.2 Middle East & Africa Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Attention Deficit and Hyperactivity Disorder Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Attention Deficit and Hyperactivity Disorder Sales Value

6.3 United States

6.3.1 United States Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

6.3.2 United States Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Attention Deficit and Hyperactivity Disorder Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

6.4.2 Europe Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Attention Deficit and Hyperactivity Disorder Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

6.5.2 China Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

6.5.3 China Attention Deficit and Hyperactivity Disorder Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

6.6.2 Japan Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Attention Deficit and Hyperactivity Disorder Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

6.7.2 South Korea Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Attention Deficit and Hyperactivity Disorder Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

6.8.2 Southeast Asia Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Attention Deficit and Hyperactivity Disorder Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Attention Deficit and Hyperactivity Disorder Sales Value, 2019-2030

6.9.2 India Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

6.9.3 India Attention Deficit and Hyperactivity Disorder Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Profile

7.1.2 Takeda Main Business

7.1.3 Takeda Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.1.4 Takeda Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.1.5 Takeda Recent Developments

7.2 Johnson & Johnson

7.2.1 Johnson & Johnson Profile

7.2.2 Johnson & Johnson Main Business

7.2.3 Johnson & Johnson Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.2.4 Johnson & Johnson Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.2.5 Johnson & Johnson Recent Developments

7.3 Novartis

7.3.1 Novartis Profile

7.3.2 Novartis Main Business

7.3.3 Novartis Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.3.4 Novartis Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.3.5 Eli Lilly Recent Developments

7.4 Eli Lilly

7.4.1 Eli Lilly Profile

7.4.2 Eli Lilly Main Business

7.4.3 Eli Lilly Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.4.4 Eli Lilly Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.4.5 Eli Lilly Recent Developments

7.5 Tris Pharma

7.5.1 Tris Pharma Profile

7.5.2 Tris Pharma Main Business

7.5.3 Tris Pharma Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.5.4 Tris Pharma Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.5.5 Tris Pharma Recent Developments

7.6 Neos Therapeutics

7.6.1 Neos Therapeutics Profile

7.6.2 Neos Therapeutics Main Business

7.6.3 Neos Therapeutics Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.6.4 Neos Therapeutics Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.6.5 Neos Therapeutics Recent Developments

7.7 Mallinckrodt

7.7.1 Mallinckrodt Profile

7.7.2 Mallinckrodt Main Business

7.7.3 Mallinckrodt Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.7.4 Mallinckrodt Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.7.5 Mallinckrodt Recent Developments

7.8 Amneal Pharmaceuticals

7.8.1 Amneal Pharmaceuticals Profile

7.8.2 Amneal Pharmaceuticals Main Business

7.8.3 Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.8.4 Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.8.5 Amneal Pharmaceuticals Recent Developments

7.9 Noven Pharmaceuticals

7.9.1 Noven Pharmaceuticals Profile

7.9.2 Noven Pharmaceuticals Main Business

7.9.3 Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.9.4 Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.9.5 Noven Pharmaceuticals Recent Developments

7.10 Purdue Parma

7.10.1 Purdue Parma Profile

7.10.2 Purdue Parma Main Business

7.10.3 Purdue Parma Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

7.10.4 Purdue Parma Attention Deficit and Hyperactivity Disorder Revenue (US$ Million) & (2019-2024)

7.10.5 Purdue Parma Recent Developments

8 Industry Chain Analysis

8.1 Attention Deficit and Hyperactivity Disorder Industrial Chain

8.2 Attention Deficit and Hyperactivity Disorder Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Attention Deficit and Hyperactivity Disorder Sales Model

8.5.2 Sales Channel

8.5.3 Attention Deficit and Hyperactivity Disorder Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Attention Deficit and Hyperactivity Disorder Market Trends

Table 2. Attention Deficit and Hyperactivity Disorder Market Drivers & Opportunity

Table 3. Attention Deficit and Hyperactivity Disorder Market Challenges

Table 4. Attention Deficit and Hyperactivity Disorder Market Restraints

Table 5. Global Attention Deficit and Hyperactivity Disorder Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Attention Deficit and Hyperactivity Disorder Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Attention Deficit and Hyperactivity Disorder Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Attention Deficit and Hyperactivity Disorder Product Type

Table 9. Key Companies Time to Begin Mass Production of Attention Deficit and Hyperactivity Disorder

Table 10. Global Attention Deficit and Hyperactivity Disorder Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit and Hyperactivity Disorder as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Attention Deficit and Hyperactivity Disorder Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Attention Deficit and Hyperactivity Disorder Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Attention Deficit and Hyperactivity Disorder Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Attention Deficit and Hyperactivity Disorder Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Attention Deficit and Hyperactivity Disorder Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Attention Deficit and Hyperactivity Disorder Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Attention Deficit and Hyperactivity Disorder Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Attention Deficit and Hyperactivity Disorder Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Attention Deficit and Hyperactivity Disorder Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Attention Deficit and Hyperactivity Disorder Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Attention Deficit and Hyperactivity Disorder Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Attention Deficit and Hyperactivity Disorder Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Attention Deficit and Hyperactivity Disorder Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Attention Deficit and Hyperactivity Disorder Sales Value by Region (2019-2024) & (%)

Table 27. Global Attention Deficit and Hyperactivity Disorder Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Attention Deficit and Hyperactivity Disorder Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Attention Deficit and Hyperactivity Disorder Sales Value, (2025-2030) & (US$ Million)

Table 31. Takeda Basic Information List

Table 32. Takeda Description and Business Overview

Table 33. Takeda Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 34. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Takeda (2019-2024)

Table 35. Takeda Recent Developments

Table 36. Johnson & Johnson Basic Information List

Table 37. Johnson & Johnson Description and Business Overview

Table 38. Johnson & Johnson Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 39. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Johnson & Johnson (2019-2024)

Table 40. Johnson & Johnson Recent Developments

Table 41. Novartis Basic Information List

Table 42. Novartis Description and Business Overview

Table 43. Novartis Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 44. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Novartis (2019-2024)

Table 45. Novartis Recent Developments

Table 46. Eli Lilly Basic Information List

Table 47. Eli Lilly Description and Business Overview

Table 48. Eli Lilly Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 49. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Eli Lilly (2019-2024)

Table 50. Eli Lilly Recent Developments

Table 51. Tris Pharma Basic Information List

Table 52. Tris Pharma Description and Business Overview

Table 53. Tris Pharma Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 54. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Tris Pharma (2019-2024)

Table 55. Tris Pharma Recent Developments

Table 56. Neos Therapeutics Basic Information List

Table 57. Neos Therapeutics Description and Business Overview

Table 58. Neos Therapeutics Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 59. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Neos Therapeutics (2019-2024)

Table 60. Neos Therapeutics Recent Developments

Table 61. Mallinckrodt Basic Information List

Table 62. Mallinckrodt Description and Business Overview

Table 63. Mallinckrodt Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 64. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Mallinckrodt (2019-2024)

Table 65. Mallinckrodt Recent Developments

Table 66. Amneal Pharmaceuticals Basic Information List

Table 67. Amneal Pharmaceuticals Description and Business Overview

Table 68. Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 69. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Amneal Pharmaceuticals (2019-2024)

Table 70. Amneal Pharmaceuticals Recent Developments

Table 71. Noven Pharmaceuticals Basic Information List

Table 72. Noven Pharmaceuticals Description and Business Overview

Table 73. Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 74. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Noven Pharmaceuticals (2019-2024)

Table 75. Noven Pharmaceuticals Recent Developments

Table 76. Purdue Parma Basic Information List

Table 77. Purdue Parma Description and Business Overview

Table 78. Purdue Parma Attention Deficit and Hyperactivity Disorder Products, Services and Solutions

Table 79. Revenue (US$ Million) in Attention Deficit and Hyperactivity Disorder Business of Purdue Parma (2019-2024)

Table 80. Purdue Parma Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Attention Deficit and Hyperactivity Disorder Downstream Customers

Table 84. Attention Deficit and Hyperactivity Disorder Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Attention Deficit and Hyperactivity Disorder Product Picture

Figure 2. Global Attention Deficit and Hyperactivity Disorder Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Attention Deficit and Hyperactivity Disorder Sales Value (2019-2030) & (US$ Million)

Figure 4. Attention Deficit and Hyperactivity Disorder Report Years Considered

Figure 5. Global Attention Deficit and Hyperactivity Disorder Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Attention Deficit and Hyperactivity Disorder Revenue in 2023

Figure 7. Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Stimulant Picture

Figure 9. Non-stimulant Picture

Figure 10. Global Attention Deficit and Hyperactivity Disorder Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Attention Deficit and Hyperactivity Disorder Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospital

Figure 13. Product Picture of Retail Pharmacy

Figure 14. Product Picture of Others

Figure 15. Global Attention Deficit and Hyperactivity Disorder Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Attention Deficit and Hyperactivity Disorder Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Attention Deficit and Hyperactivity Disorder Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Attention Deficit and Hyperactivity Disorder Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Attention Deficit and Hyperactivity Disorder Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Attention Deficit and Hyperactivity Disorder Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Attention Deficit and Hyperactivity Disorder Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Attention Deficit and Hyperactivity Disorder Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Attention Deficit and Hyperactivity Disorder Sales Value (%), (2019-2030)

Figure 28. United States Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Attention Deficit and Hyperactivity Disorder Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Attention Deficit and Hyperactivity Disorder Sales Value by Application (%), 2023 VS 2030

Figure 34. China Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

Figure 36. China Attention Deficit and Hyperactivity Disorder Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Attention Deficit and Hyperactivity Disorder Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Attention Deficit and Hyperactivity Disorder Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Attention Deficit and Hyperactivity Disorder Sales Value by Application (%), 2023 VS 2030

Figure 46. India Attention Deficit and Hyperactivity Disorder Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Attention Deficit and Hyperactivity Disorder Sales Value by Type (%), 2023 VS 2030

Figure 48. India Attention Deficit and Hyperactivity Disorder Sales Value by Application (%), 2023 VS 2030

Figure 49. Attention Deficit and Hyperactivity Disorder Industrial Chain

Figure 50. Attention Deficit and Hyperactivity Disorder Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Attention Deficit and Hyperactivity Disorder in 2024? zhanKai

The global market size of Attention Deficit and Hyperactivity Disorder in 2024 was 20500 Million USD.

What is the annual compound growth rate of the global Attention Deficit and Hyperactivity Disorder market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Attention Deficit and Hyperactivity Disorder market? shouQi

What was the global market size of Attention Deficit and Hyperactivity Disorder in 2030? shouQi

Related Reports

Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025
The global market for Attention Deficit and Hyperactivity Disorder was valued at US$ 20500 million in the year 2024 and is projected to reach a revised size of US$ 32710 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published Date: 2025-01-01
Pages: 80
USD 2900.00
(Single User License)
Global Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2030
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published Date: 2024-04-12
Pages: 105
USD 4900.00
(Single User License)
Global Attention Deficit and Hyperactivity Disorder Market Research Report 2024
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published Date: 2024-01-12
Pages: 80
USD 2900.00
(Single User License)

Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025
The global market for Attention Deficit and Hyperactivity Disorder was valued at US$ 20500 million in the year 2024 and is projected to reach a revised size of US$ 32710 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published: 2025-01-01
Pages: 80
USD 2900.00 (Single User License)
Global Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2030
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published: 2024-04-12
Pages: 105
USD 4900.00 (Single User License)
Global Attention Deficit and Hyperactivity Disorder Market Research Report 2024
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Published: 2024-01-12
Pages: 80
USD 2900.00 (Single User License)